Latest news about Nath Bio-Genes
Nath Bio-Genes
138.28
+2.49(+1.83%)
Company Performance:
View Company Insights1D+1.83%
1M-6.43%
6M-9.59%
1Y-22.04%
5Y-57.32%
More news about Nath Bio-Genes
30Apr 26
Nath Bio-Genes Board Meeting May 4 & Earnings Call May 5 for Q4FY26 Results
Nath Bio-Genes has scheduled a comprehensive Q4FY26 results disclosure process with board meeting on May 4, 2026 to approve audited financial results and consider dividend recommendations, followed by earnings conference call on May 5, 2026 at 4:00 PM IST hosted by Go India Advisors featuring key management personnel including MD Satish Kagliwal and CFO Amol Gupta.
16Apr 26
Nath Bio-Genes Submits Compliance Certificate for Q4FY26 Under SEBI Regulations
Nath Bio-Genes (I) Ltd. has submitted its compliance certificate for Q4FY26 ended 31st March 2026 under SEBI Regulation 74(5) to BSE and NSE. The certificate, received from registrar Bigshare Services Pvt. Ltd., confirms proper processing of dematerialized securities and compliance with regulatory requirements. The submission was made on 15th April 2026 by CFO Amol Gupta, ensuring adherence to depositories and participants regulations.
13Jan 26
Tapovan Paper and Board Mills Acquires 0.40% Stake in Nath Bio-Genes Through Amalgamation Scheme
Tapovan Paper and Board Mills Limited acquired 75,645 equity shares (0.40%) in Nath Bio-Genes (India) Limited through an NCLT-approved amalgamation scheme. The shares were transferred from two transferor companies that ceased to exist following the amalgamation completed on January 9, 2026. The acquisition maintains the overall promoter group shareholding at 45.60% without changing the aggregate promoter holding structure.
18Nov 25
NathBio-Genes Reports 15.9% Revenue Growth to INR 3,199 Million in H1 FY26, Driven by Strong Cotton and Vegetable Seed Performance
Nath Bio-Genes (India) Limited reported strong financial results for H1 FY26, with revenue increasing by 15.9% to INR 3,199.00 million and PAT growing by 15.3% to INR 424.00 million. The growth was driven by strong performances in cotton (26.3% value growth) and vegetable seeds (25% year-on-year growth) segments. The company maintained its market position despite challenges such as erratic monsoons and illegal BT cotton spread. Management expressed optimism about future growth prospects, particularly in vegetable seeds and Plant Nutrition Solutions segments.
14Nov 25
NathBio-Genes Reports 23.5% Revenue Growth to Rs 398 Mn in Q2FY26, PAT Surges 45.4%
Nath Bio-Genes (India) Limited reported a 23.5% year-on-year revenue increase to Rs 398 million in Q2FY26. Profit After Tax grew by 45.4% to Rs 42 million. The cotton segment saw a 6.3% growth to 1.11 million packets, while the vegetable seeds segment recorded a 24.4% growth. Gross margins expanded to 68% from 60% in the previous year. The company's joint venture in Uzbekistan is operating successfully, contributing to its international presence.
11Jul 25
Nath Bio-Genes Reports Strong Q1 FY2026 Results with 12.7% Profit Growth
Nath Bio-Genes (India) Limited announced strong Q1 FY2026 results with revenue increasing 14.9% to ₹280.17 crore and net profit rising 12.7% to ₹38.21 crore compared to the same period last year. Operating profit grew 4.7% to ₹37.93 crore. The company's Board approved the appointment of Ms. Payal Jain as an Additional Director, pending shareholder approval for her role as Independent Director.
Industry Peers
LT Foods
KRBL
Gujarat Ambuja Exports
Trualt Bioenergy
Kaveri Seed Company
Amir Chand Jagdish Kumar (Exports)
Sanstar
GRM Overseas
Avt Natural Products
Chaman Lal Setia Exports
411.40
(-0.74%)
389.45
(-0.92%)
166.89
(+0.02%)
435.80
(-1.68%)
700.45
(-0.28%)
217.45
(-1.46%)
100.70
(+1.71%)
86.62
(-1.55%)
94.90
(-2.67%)
281.05
(-2.33%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
